Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Selander

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
BMC Pulmonary Medicine|August 14, 2022
Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseasesMinna Mononen, Eeva Saari, Hannele Hasala, et al.
Multiple Sclerosis and Related Disorders|October 9, 2021
Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosisMarja Niiranen, Aleksi Kontkanen, Olli Jääskeläinen, et al.
Leukemia & Lymphoma|February 6, 2021
Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 monthsAino Rajamäki, Kaisa Sunela, Roosa E I Prusila, et al.
Intensive Care Medicine|May 7, 2021
Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trialSuvi T Vaara, Marlies Ostermann, Laurent Bitker, et al.
Hemasphere|September 11, 2023
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion CriteriaMinna Harmanen, Tuula Klaavuniemi, Marc Sorigue, et al.
Cancer Medicine|November 23, 2025
Prolonged Time From Symptoms to Diagnosis Is Associated With an Inferior Progression-Free Survival in Diffuse Large B-Cell LymphomaSusanna Tokola, Katja Marin, Milla E L Kuusisto, et al.
Leukemia & Lymphoma|May 19, 2020
Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA studyAntti Turunen, Jaakko Valtola, Anu Partanen, et al.
European Heart Journal|August 27, 2023
Critical limb-threatening ischaemia and microvascular transformation: clinical implicationsSanteri Tarvainen, Galina Wirth, Greta Juusola, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2023
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse eventsAnna Jokimäki, Henna Hietala, Jasmiini Lemma, et al.
Annals of Hematology|November 2, 2019
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma GroupSini Luoma, Pekka Anttila, Marjaana Säily, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
BMC Pulmonary Medicine|August 14, 2022
Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseasesMinna Mononen, Eeva Saari, Hannele Hasala, et al.
Multiple Sclerosis and Related Disorders|October 9, 2021
Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosisMarja Niiranen, Aleksi Kontkanen, Olli Jääskeläinen, et al.
Leukemia & Lymphoma|February 6, 2021
Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 monthsAino Rajamäki, Kaisa Sunela, Roosa E I Prusila, et al.
Intensive Care Medicine|May 7, 2021
Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trialSuvi T Vaara, Marlies Ostermann, Laurent Bitker, et al.
Hemasphere|September 11, 2023
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion CriteriaMinna Harmanen, Tuula Klaavuniemi, Marc Sorigue, et al.
Cancer Medicine|November 23, 2025
Prolonged Time From Symptoms to Diagnosis Is Associated With an Inferior Progression-Free Survival in Diffuse Large B-Cell LymphomaSusanna Tokola, Katja Marin, Milla E L Kuusisto, et al.
Leukemia & Lymphoma|May 19, 2020
Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA studyAntti Turunen, Jaakko Valtola, Anu Partanen, et al.
European Heart Journal|August 27, 2023
Critical limb-threatening ischaemia and microvascular transformation: clinical implicationsSanteri Tarvainen, Galina Wirth, Greta Juusola, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2023
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse eventsAnna Jokimäki, Henna Hietala, Jasmiini Lemma, et al.
Annals of Hematology|November 2, 2019
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma GroupSini Luoma, Pekka Anttila, Marjaana Säily, et al.
Pageof 15